Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating IVIEW-1201 for acute bacterial conjunctivitis have been reported, detailing the treatment's efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• IVIEW-1201

Snippet

Sponsor: IVIEW Therapeutics Inc. | Conditions: Acute Bacterial Conjunctivitis | Phase 2 | Status: COMPLETED | Results posted: 2025-06-15